BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8578518)

  • 1. Thrombopoietin: the primary regulator of megakaryocyte and platelet production.
    Kaushansky K
    Thromb Haemost; 1995 Jul; 74(1):521-5. PubMed ID: 8578518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the distal half of the c-Mpl intracellular domain in control of platelet production by thrombopoietin in vivo.
    Luoh SM; Stefanich E; Solar G; Steinmetz H; Lipari T; Pestina TI; Jackson CW; de Sauvage FJ
    Mol Cell Biol; 2000 Jan; 20(2):507-15. PubMed ID: 10611229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic stem cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoietin.
    Kimura S; Roberts AW; Metcalf D; Alexander WS
    Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1195-200. PubMed ID: 9448308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombopoietin: a tool for understanding thrombopoiesis.
    Kaushansky K
    J Thromb Haemost; 2003 Jul; 1(7):1587-92. PubMed ID: 12871295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombopoietin, the Primary Regulator of Platelet Production: From Mythos to Logos, a Thirty-Year Journey.
    Kaushansky K
    Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of thrombopoietin on the development of megakaryocytes and platelets: an ultrastructural analysis.
    Zucker-Franklin D; Kaushansky K
    Blood; 1996 Sep; 88(5):1632-8. PubMed ID: 8781418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naturally Occurring Bicoumarin Compound Daphnoretin Inhibits Growth and Induces Megakaryocytic Differentiation in Human Chronic Myeloid Leukemia Cells.
    Huang YC; Huang CP; Lin CP; Yang KC; Lei YJ; Wang HP; Kuo YH; Chen YJ
    Cells; 2022 Oct; 11(20):. PubMed ID: 36291120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Recombinant Human Thrombopoietin for the Treatment of Secondary Failure of Platelet Recovery After Allogeneic HSCT.
    Cao Y; Wang M; Shen B; Zhao F; Zhang R; Chen X; He Y; Zhai W; Ma Q; Wei J; Huang Y; Yang D; Pang A; Feng S; Jiang E; Han M
    Clin Appl Thromb Hemost; 2022; 28():10760296211068037. PubMed ID: 35019756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Bone Marrow Microenvironment Mechanisms in Acute Myeloid Leukemia.
    Pimenta DB; Varela VA; Datoguia TS; Caraciolo VB; Lopes GH; Pereira WO
    Front Cell Dev Biol; 2021; 9():764698. PubMed ID: 34869355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Craniofacial Bone Tissue Engineering: Current Approaches and Potential Therapy.
    Aghali A
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards a New Understanding of Decision-Making by Hematopoietic Stem Cells.
    Brown G
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicological profile of the aqueous-fermented extract of
    Ugbogu EA; Ude VC; Elekwa I; Arunsi UO; Uche-Ikonne C; Nwakanma C
    Avicenna J Phytomed; 2018; 8(6):478-487. PubMed ID: 30456195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baricitinib-induced blockade of interferon gamma receptor and interleukin-6 receptor for the prevention and treatment of graft-versus-host disease.
    Choi J; Cooper ML; Staser K; Ashami K; Vij KR; Wang B; Marsala L; Niswonger J; Ritchey J; Alahmari B; Achilefu S; Tsunoda I; Schroeder MA; DiPersio JF
    Leukemia; 2018 Nov; 32(11):2483-2494. PubMed ID: 29691471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From chronic immune thrombocytopenia to severe aplastic anemia: recent insights into the evolution of eltrombopag.
    Gill H; Wong RSM; Kwong YL
    Ther Adv Hematol; 2017 May; 8(5):159-174. PubMed ID: 28473904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role and clinical implications of the endosteal niche and osteoblasts in regulating leukemia.
    Azizidoost S; Vijay V; Cogle CR; Khodadi E; Saki N
    Clin Transl Oncol; 2017 Sep; 19(9):1059-1066. PubMed ID: 28281084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of acute and sub-chronic oral toxicity study of Baker Cleansers Bitters - a polyherbal drug on experimental rats.
    Patrick-Iwuanyanwu KC; Amadi U; Charles IA; Ayalogu EO
    EXCLI J; 2012; 11():632-640. PubMed ID: 27847451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and Subchronic Oral Toxicity Evaluation of Aqueous Root Extract of Dicoma anomala Sond. in Wistar Rats.
    Balogun FO; Tom Ashafa AO
    Evid Based Complement Alternat Med; 2016; 2016():3509323. PubMed ID: 27200099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombocytopenia in MDS: epidemiology, mechanisms, clinical consequences and novel therapeutic strategies.
    Li W; Morrone K; Kambhampati S; Will B; Steidl U; Verma A
    Leukemia; 2016 Mar; 30(3):536-44. PubMed ID: 26500138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Management of Primary Immune Thrombocytopenia.
    Provan D; Newland AC
    Adv Ther; 2015 Oct; 32(10):875-87. PubMed ID: 26499177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged thrombocytopenia after living donor liver transplantation is a strong prognostic predictor irrespective of splenectomy: the significance of ADAMTS13 and graft function [corrected].
    Nobuoka Y; Wada H; Mizuno S; Kishiwada M; Usui M; Sakurai H; Tabata M; Kobayashi T; Nobori T; Uemoto S; Isaji S
    Int J Hematol; 2014 Apr; 99(4):418-28. PubMed ID: 24595551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.